Brenda Marie Rivers
Booz Allen Hamilton has been awarded a potential $36M contract to support an information technology platform the Food and Drug Administration uses to monitor adverse drug events.
The company subsequently received a $5.6M initial task order under the indefinite-delivery/indefinite-quantity that covers IT life cycle services for FDA Adverse Event Reporting System, according to a notice posted Tuesday on FedBizOpps.
Work will include pharmacovigilance and analytics software licenses; software maintenance and operational support; training; and IT development, configuration and implementation services.
The agency noted its FAERS is designed to store user-submitted medication safety reports and support post-marketing surveillance of drug and therapeutic biologic products.
